Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research

Summary

Keenova Therapeutics announced publication of a new manuscript on Acthar Gel for treating severe autoimmune diseases in the Journal of Comparative Effectiveness Research. The retrospective, physician-reported study was sponsored by Keenova.